Background: There are a variety of growth hormone delivery devices (GHDD) available to children requiring growth hormone (GH) therapy. Many paediatric endocrine nurses can offer patients and their families a choice of the products that are available, which can sometimes be overwhelming. However, factors such a licenced clinical indications have to be considered, as well as cost. This study explored nurses viewpoints on GHDD. Aims: The purpose of this project was to explore whether other factors should be considered when exploring choice of GHDD. Methods: Participating nurses (N = 10) attended an interactive training session on all of the GHDD. Subsequently, each nurse was given a box of marketing materials for each GHDD, including training materials, patient information literature and DVDs. The nurses were given five case study scenarios on different conditions, and were advised to work in pairs. In their groups, the nurses were asked for feed back on their choice of GHDD, detailing why they had chosen that specific device, utilising a problem based learning approach. Themes were extrapolated using thematic analysis. Results: Nurses had a variety of devices to choose from (N = 11): three groups had chosen different devices (N = 3) apart from two groups had chosen the same device. Influencing themes that emerged included: knowledge of patients' learning difficulties, social and housing implications, child's body composition, child friendly device design, and ease of use. Cost was also discussed, but was not the deciding factor for a final decision. Conclusions: Themes that emerged from the study demonstrate that the nurses' clinical judgement and prior knowledge of the patient's needs is an intrinsic factor to consider when implementing patient choice in GHDD. Clinical Implications: Further research needs to be conducted on a larger scale to examine nurses' thoughts and opinions on the different GHDDs available, and the need to remain conscious of underlying issues which may not be obvious or apparent to the child and family. From this, a reduced number of choice of devices can therefore be demonstrated to children and their families, thereby giving the nurse more time to focus on the most appropriate devices. Background: New York University Langone Medical Center (NYULMC) opened The Pediatric Diabetes Center in February 2016 to provide specialized pediatric diabetes care, including diabetes selfmanagement education (DSME), self-management support (DSMS), nutrition, and psycho-social healthcare. As recommended by the American Diabetes Association (ADA), in order to increase the quality of care, a healthcare system must: expand the role of teams, redesign the care process, empower and educate patients, and address psycho-social issues. Prior to the opening of The Diabetes Center, the average HbA1c of the pediatric diabetes patient at NYU was 9.2%. Aims: The aim of this Quality Improvement (QI) Project was to decrease the average HbA1c by 0.5% in a 6 month period. Methods: In an effort to improve the quality of care of our pediatric diabetes patients with the goal of decreasing HbA1c levels, NYULMC developed a diabetes education program based on the ADA recommendations through:
1. Recruitment of a diabetes team including certified diabetes educators (RN, RD). 2. Collaboration with integrated behavioral health team (SW, psych, child-life). 3. Obtaining ADA recognition and creation of a six week educational program using DSMS and DSME materials. 4. Weekly team meetings to discuss patients and program initiatives. 5. Community outreach (patient events, education for providers, etc.).
Results:
We evaluated HbA1c levels of 26 pediatric diabetes patients seen at NYULMC prior to, and following, the creation of the diabetes program. We reviewed HbA1c at four points: pre-program, first diabetes team visit, three month follow-up, and six month follow-up. The average HbA1c, of the subjects (n = 26), at the six month visit decreased by 0.5%, to 8.4%, when compared to HbA1c at the first diabetes team visit (*p = 0.01, paired t-test). Conclusions: Following the ADA guidelines and providing patients with a team of diabetes educators that can provide DSME and DSMS, as well as collaboration with other departments, may contribute to improved quality of patient care as measured by a decrease in the HbA1c levels of patients. Clinical Implications: Pediatric nurses specialized in diabetes education must be included on a team providing care to pediatric patients with diabetes if quality care is expected. Following the creation of the diabetes program, which included diabetes educators, The Pediatric Diabetes Center was able to provide ADA recommended DSME and DSMS and decrease HbA1c levels. Pediatric patients with diabetes may benefit from being referred to health care providers able to provide a team with nurses specialized in diabetes care to patients. Background: Guidelines of the International Society for Pediatric and Adolescent Diabetes (ISPAD) recommend screening for DR in children with T1D starting at age 10 with at least 2 years of T1D. Compliance has been shown to be compromised by barriers including access. It may be argued that screening could be optimized if offered in a convenient way in a standardized fashion. Aims: To evaluate the prevalence of DR in youth that comply with ISPAD screening criteria and assess differences between those that had their screening done at their routine diabetes clinic visit (DCV) vs those that had it at an outside ophthalmology office. Methods: Patients with T1D during the period 02/01/15-01/31/16 were identified by Registered Nurse and medical records reviewed. Those screened at the same time of their DCV had mydriatic digital fundal photography reviewed by an experienced pediatric ophthalmologist. Reports of DR status of patients with screening performed at an outside ophthalmology office were collected by the Registered Nurse. Results: 418 individuals met screening criteria, 190 were screened at DCV and 228 individuals at outside ophthalmology office s. Subjects who underwent screening at DC were more likely to be African American (16% vs. 2%, p b 0.0001), had worse glycemic control (HbA1c 8.9% vs. 8.2%, p = 0.0002), higher LDL cholesterol (98 mg/dl vs. 91 mg/dl, p = 0.05) and less likely to be using insulin pumps (33% vs. 51%, p = 0.0001). Overall, 10 subjects (2.4%) had evidence of mild, non-proliferative DR: 9 were screened at DCV (p = 0.006). 8 of the 10 patients were African American (p b 0.0001). Subjects with evidence of DR, compared to those without were older at screening (17.1 vs. 15.3 years, p = 0.05), had longer duration of T1D (10.2 vs. 7.1 years, p = 0.007) and worse glycemic control (HbA1c 11.2vs. 8.4%, p = 0.008). Conclusions: The prevalence of DR was higher among subjects screened through our in-house initiative than among subjects who were screened through outside ophthalmology offices. Those that elected to be screened at DCV had higher prevalence of risk factors for development of DR. Clinical Implications: These data support the importance of having DR screening in conjunction to DCV in order to reach high risk patients. Background: Type 1 diabetes mellitus (T1DM) requires lifelong insulin therapy. Glycemic control, self-management and continuity of care are key for minimizing longterm complications. The rising incidence/prevalence of T1DM is challenging health systems to find effective ways to transition young adults from pediatric to adult-oriented services. Presently, there is a paucity of evidence regarding T1DM transition programs from hospital to communitybased settings and patient perspectives are rarely taken into account. Aims: In the context of a pilot transitional care project featuring nurse-led consultations we sought to: i) assess adherence to self-care recommendations, ii) examine the therapeutic relationship from the patient point of view, iii) assess patient satisfaction and links with caring attitudes/behaviors. Methods: The project aimed to develop/implement a structured T1DM transition consultation. This included nurse-led consultations to accompany and guide patients from pediatric to adult-oriented settings. We conducted a descriptive, cross-sectional study of patients (16-25 years). When possible, glycated hemoglobin (HbA1c) measures were collected and patients completed the Self-Care Inventory Revised (SCI-R) and Caring Nurse-Patient Interaction Scale (EIIP-23P). Results: In total 20/58 (34%) of patients (20.1 ± 2.5 years) responded to the survey. Only 3/14 (21%) met the ADA target for HbA1c (only one met NICE criteria). Patients reported the highest adherence ratings for medication and managing hypoglycemia (both 4.5 out of 5) while diet was lowest (2.75). Patients rated respect for privacy and basic needs as the most important (and most frequently observed) type of nursing care. Diabetes knowledge and technical competence were cited as very important. Overall, satisfaction ratings was (4 out of 5) and patients were most satisfied with the humanistic aspects of nursing care (i.e. encouraging/accompanying patient). Conclusions: Reaching HbA1c targets remains challenging. Young adults value healthcare professional who respect individuality and autonomy. Patients were satisfied with nurse-led consultations. Clinical Implications: Nurse-led transitional care is one response to the growing numbers of patients with T1DM. To be effective in such roles, nurses need to be knowledgeable, have technical competence and must employ a humanistic approach -providing support and encouragement for patients to draw on internal coping resources. 
